Free Trial

NRx Pharmaceuticals (NRXPW) Competitors

$0.08 +0.02 (+23.67%)
As of 01:08 PM Eastern

NRXPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

NRx Pharmaceuticals vs.

NRx Pharmaceuticals (NASDAQ:NRXPW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NRx PharmaceuticalsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NRx PharmaceuticalsN/A N/A N/A
180 Life Sciences N/A N/A N/A

NRx Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
NRx PharmaceuticalsN/AN/A
180 Life SciencesN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.59 beat NRx Pharmaceuticals' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
NRx Pharmaceuticals Neutral
180 Life Sciences Positive

Summary

180 Life Sciences beats NRx Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

Get NRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXPW vs. The Competition

MetricNRx PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$123.37M$5.43B$7.89B
Dividend YieldN/A3.69%5.37%4.22%
P/E RatioN/A3.2922.6718.76
Price / SalesN/A4,144.03388.16108.12
Price / CashN/A13.0238.2534.62
Price / BookN/A34.126.704.24
Net IncomeN/A-$90.45M$3.23B$247.85M
7 Day PerformanceN/A-0.52%-1.97%0.40%
1 Month PerformanceN/A8.57%8.86%11.67%
1 Year PerformanceN/A93.86%15.00%2.91%

NRx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRXPW
NRx Pharmaceuticals
N/A$0.08
+23.7%
N/A-35.6%$0.00N/A0.00N/AGap Up
ATNFW
180 Life Sciences
N/A$0.01
+3.8%
N/A-9.9%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.23
-12.1%
N/A+191.1%$0.00$20,729.000.0040Gap Up
ALVOW
Alvotech
N/A$1.29
-2.3%
N/A-60.6%$0.00$489.68M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.04
+22.7%
N/AN/A$0.00$37.32M0.0070Gap Up
BTMDW
biote
N/A$0.01
+5.7%
N/AN/A$0.00$197.19M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.09
-20.8%
N/A-89.0%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
N/A$0.00
-98.0%
N/A-99.5%$0.00N/A0.0060Gap Down

Related Companies and Tools


This page (NASDAQ:NRXPW) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners